Takeda Pharmaceutical Co Ltd ADR (TAK)

Currency in USD
14.16
+0.44(+3.21%)
Closed·
Pre Market
14.09-0.07(-0.49%)
·

TAK Financial Summary

Key Ratios

P/E Ratio48.63
Price/Book0.96
Debt / Equity73.42%
Return on Equity1.87%
Dividend Yield3.84%
EBITDA1.23T
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of JPY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 86.78%
Dividend Yield
3.84%
Industry Median 2.85%
Annualised payout
0.54
Paid unevenly
5-Years Growth
+1.72%
Growth Streak

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 16.89
(+19.29% Upside)

Earnings

Latest Release
Jul 30, 2025
EPS / Forecast
151.00 / 0.1764
Revenue / Forecast
1.11T / 8.06B
EPS Revisions
Last 90 days

FAQ

What were Takeda Pharma ADR's earnings for the latest quarter?

The Takeda Pharma ADR EPS (TTM) is 86.78. Takeda Pharma ADR reported sales of 1,106,685.00, net income of 124,243.00, and EPS of 151.00 for the latest quarter.

What was Takeda Pharma ADR's net income for the latest quarter?

Takeda Pharma ADR's net income for the latest quarter was 124,243.00.

How did Takeda Pharma ADR's performance compare year-over-year in the latest quarter?

The company's revenue moved from 1,053,399.00 in the previous quarter to 1,106,685.00 in the latest quarter, and net income moved from -103,155.00 to 124,243.00 compared to the previous quarter.

What is Takeda Pharma ADR's net profit margin on a TTM basis?

Takeda Pharma ADR's trailing twelve months (TTM) net profit margin is 2.36%.

How does Takeda Pharma ADR's debt to equity ratio compare to industry standards?

Takeda Pharma ADR's total debt-to-equity ratio is 73.42%.

What is Takeda Pharma ADR's return on investment on a TTM basis?

Takeda Pharma ADR's trailing twelve months (TTM) return on investment (ROI) is 1.87%.

Did Takeda Pharma ADR gain or lose cash last quarter?

In the latest quarter, Takeda Pharma ADR's net change in cash was -35,105.00 million.

What were Takeda Pharma ADR's total assets and liabilities in the latest quarter?

As of the latest quarter, Takeda Pharma ADR reported total assets of 14,004,537.00 million and total liabilities of 2,169,586.00 million.

How has Takeda Pharma ADR's total revenue grown this year?

Takeda Pharma ADR's total revenue was 1,053,399.00 in the previous quarter and 1,106,685.00 in the latest quarter.

What is Takeda Pharma ADR's gross margin on a TTM basis?

Takeda Pharma ADR's trailing twelve months (TTM) gross margin is 64.98%.

What was Takeda Pharma ADR's revenue per share for the latest quarter?

Takeda Pharma ADR's revenue per share for the latest quarter was 43.95.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.